Clinical results of thymectomy in myasthenia gravis patients

Document Type : Original

Authors

1 Mashhad University of Medical Ghaem - Department of Thoracic and Cardiovascular Surgery

2 Professor of Neurology and Psychiatry Department of Qayim Hospital

3 Assistant Professor of the Lung Department of Qayim Hospital

4 Assistant professor of heart and thoracic surgery department

5 General practitioner

Abstract

Introduction: myasthenia gravis is an autoimmune disorder affecting postsynaptic acetylcholine receptors of voluntary muscles. Since Blalock et al. first demonstrated the beneficial effect of thymectomy in 1939. The procedure has become increasingly accepted in the treatment of myasthenia gravis.
Materials and Methods: we studied clinical results of thymectomy in myasthenia gravis cases during 12 years retrospectively and antegradly. Our variables included: patient's age, sex, and signs at the time of admission, disease onset to operation interval, postoperative complications, and duration of hospitalization, thymus histology and clinical response to thymectomy. Data were analyzed appropriate analysis.
Results: 16 women and 11 men with median age of 29.8 (±12.7) years were operated on by median sternotomy approach. Thymectomy was done during less than 1 year after disease onset in 44%, 1-3 years later in 42% and later than 3 years in 14%. Most had mild to moderate generalized myasthenia. Thymic hyperplasia was reported to be the most common pathologic finding. Clinical response to thymectomy was good (70.4%). The best results were obtained in female less than 40 years old, with out thymoma, disease onset to operation interval less than 2 years and mild myasthenia.
Conclusion: Because of its high beneficial rate thymectomy is an advantageous therapeutic option. The chance of benefit increases when the history of myasthenia gravis is short and the stage of the disease is early.

Keywords


1- Sanders DB, Howard JF. Disorders of neuromuscular transmission. In: Bradely WG, Daroff  RB, Fenichol GM, Mardson CD. Eitors. Neurology in clinical practice: Principles of diagnosis and management. Washington: Butterworth- Heinman press; 1996. p. 1983.  
2- Kirschner PA. The history of surgery of thymic gland. Chest surg clin n am 2000, 10: 153-65.
 3- Balock A, Mason MF, Morgan HJ, Riven SS. Myasthenia gravis and tumors of thymic region, report of a case in which a tumor was removed. ann surg, 1993; 110: 554- 61.  
4- Masoka Y, Niwa H, Fulcai I et al. Extended thymectomy for myasthenia gravis patients: A 20-year review. ann thorac surg 1996, 62: 953-9.  
5- Bril V, Kojic J, Iise Wk et al: Long- term outcome after cervical thymectomy for Myasthenia gravis patients. Ann thorac surg 1998, 65: 1520-2.  
6- Nieto IP, Robledo JP, Pajuello MC et al. Prognostic factors for myasthenia gravis treated by thymectomy: review of 61 cases. Ann thorac surg 1999, 67: 1568-71.   
7- Gronseth GS, Barohli RJ: Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the quality Subcommittee of the American Academy of Neurology. Ann Thorac Surg 2000, 70: 327-34.  8- Huang CS, Hsu, Huang BS, Lee HC, Kao KP, Hsu WH et al, Factors influencing the out come of transsternal thymectomy for myasthenia gravis. Acta neurol scand 2005; 12(2): 108-14.
9- Glinjongol C, Paiboonpol S. Out come after transsternal radical thymectomy for myasthenia gravis:14- year review at ratchaburi Hospital, J Med Assos Thai 2004; 87 (11): 1304-10.
10- Lopez-Cano M, Ponseti Bosch JM, Espin Basany E et al. Predictors of , survival in patients with Myasthenia gravis and thymoma . Med Clin (Barc) 2003, 120: 401-4.
11- Evoli A, Minisci C, Di Schino C et al: Thymoma in patients with MG: characteristics and longterm outcome. Neurology 2002, 59: 1844-50.  
12- Nagayasu T, Yamayoshi T, Matsumoto K, Ide N, Hashizume S, Nomura M et al, Beneficial effects of plasmapheresis before thymectomy on the outcome in myasthenia gravis, Jpn J thorac cardiovasc surg             2005; 53(1): 2-7.  
13- Barka A. Anesthesia and critical care of thymectomy for myasthenia gravis, Chest surg clin N am, 2001, May, 11 (2): 337-6.